Physician

Amanda Leigh Parks, M.D.

According to 2025 Medicare claims, Amanda Parks, M.D. (NPI: 1801058474) practices infectious disease in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is MISSION HEALTH COMMUNITY MULTISPECIALTY PROVIDERS, LLC (NPI: 1366912586; TIN: 832048888) and primary practice location at 28801-4601. Parks is affiliated with the Mission Health Partners, LLC (ACO ID: A2591) and AdvantagePoint Health Alliance - Western North Carolina, LLC (ACO ID: A5039), participating under the MSSP model.

Parks' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 163 traditional Medicare patients, billed 348 HCPCS/CPT codes, and received $34,685 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 343 prescription claims across 78 beneficiaries totaling $202,840 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). Open Payments data shows 5 records totaling $194. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $101,365 to $34,685. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $135,106 and ending at $202,840. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	319	1,047	$101,365
2016	364	1,112	$112,377
2017	176	420	$40,523
2018	157	286	$26,887
2019	138	257	$23,047
2020	199	394	$36,678
2021	165	285	$29,655
2022	191	401	$37,201
2023	167	355	$35,182
2024	163	348	$34,685

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	113	545	$135,106
2016	143	783	$489,588
2017	101	576	$308,343
2018	74	626	$641,920
2019	59	999	$1,257,344
2020	73	950	$1,515,980
2021	71	950	$1,843,584
2022	88	309	$493,287
2023	69	288	$225,537
2024	78	343	$202,840

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	25	58	$133
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	31	32	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	11	12	$96
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	87	154	$88
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	33	42	$57

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	13	380	$50,690
Daptomycin	Daptomycin	35	256	$37,517
Ertapenem	Ertapenem Sodium	12	80	$9,620
Vancomycin Hcl	Vancomycin Hcl	13	83	$2,411
Cefazolin Sodium	Cefazolin Sodium	19	127	$924

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$194	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amanda Leigh Parks, M.D.?

Tedicare shows public-source Medicare data for Amanda Leigh Parks, M.D. (NPI 1801058474), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amanda Leigh Parks, M.D. have ACO affiliation data?

Amanda Leigh Parks, M.D. is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591) and AdvantagePoint Health Alliance - Western North Carolina, LLC (MSSP, ACO ID A5039).

What billing organization is linked to Amanda Leigh Parks, M.D.?

Amanda Leigh Parks, M.D. is linked to MISSION HEALTH COMMUNITY MULTISPECIALTY PROVIDERS, LLC (billing NPI 1366912586) in the available physician profile data.

Does Amanda Leigh Parks, M.D. have Open Payments data?

Amanda Leigh Parks, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.